Axxam provides integrated early discovery services and solutions across the life sciences industry. We support pharmaceutical and biotech companies, start-ups, patient foundations, and academic groups in their journey from target assessment to lead optimization across all therapeutic areas and target classes. Axxam’s services comprise assay development, hit identification, including high-throughput screening, and hit-to-lead activities.